Parnassus Investments’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$127M Buy
642,138
+23,278
+4% +$4.49M 0.37% 46
2025
Q4
$114M Sell
618,860
-27,642
-4% -$4.85M 0.3% 50
2025
Q3
$99.2M Buy
646,502
+3,012
+0.5% +$456K 0.23% 58
2025
Q2
$89.9M Buy
643,490
+31,110
+5% +$4.36M 0.21% 62
2025
Q1
$90M Buy
612,380
+22,871
+4% +$3.31M 0.22% 67
2024
Q4
$77.2M Buy
589,509
+585,806
+15,820% +$82M 0.17% 84
2024
Q3
$577K Sell
3,703
-1,303
-26% -$210K ﹤0.01% 126
2024
Q2
$781K Buy
5,006
+200
+4% +$30.1K ﹤0.01% 124
2024
Q1
$651K Buy
4,806
+2,485
+107% +$329K ﹤0.01% 130
2023
Q4
$313K Buy
2,321
+658
+40% +$85.5K ﹤0.01% 128
2023
Q3
$225K Sell
1,663
-687
-29% -$93.8K ﹤0.01% 137
2023
Q2
$336K Sell
2,350
-566
-19% -$83.3K ﹤0.01% 126
2023
Q1
$405K Buy
2,916
+963
+49% +$130K ﹤0.01% 120
2022
Q4
$265K Buy
+1,953
New +$245K ﹤0.01% 129

Other funds holding AZN